Annual Drug Patent Expirations for BREXAFEMME
Brexafemme is a drug marketed by Scynexis and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has nineteen patent family members in eighteen countries.
The generic ingredient in BREXAFEMME is ibrexafungerp citrate. One supplier is listed for this compound. Additional details are available on the ibrexafungerp citrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published at New patent for Scynexis drug BREXAFEMME